Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure

doi:10.3748/wjg.v19.i48.9432

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7002)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

442

HTML

3859

Figures (1-3)

224

Tables (1-3)

210

Sum=4735

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1130

Download

1137

Sum=2267

Dec 28, 2013 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (43)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 28, 2013; 19(48): 9432-9438
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9432

Full Size Figure Download Figure

Figure 1 Scatter plots. A: Serum cystatin C (CysC) level vs model for end-stage liver disease (MELD) score; B: Serum CysC level vs serum creatinine (Cr) level.

Citation: Wan ZH, Wang JJ, You SL, Liu HL, Zhu B, Zang H, Li C, Chen J, Xin SJ. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol 2013; 19(48): 9432-9438
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9432.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9432